RCEL AVITA Medical, Inc.
Healthcare$4.25-7.21%ClosedMarket Cap: $105.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-60.38
P/S
1.57
EV/EBITDA
-2.88
DCF Value
$-43.83
FCF Yield
-27.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
81.4%
Operating Margin
-54.6%
Net Margin
-62.7%
ROE
305.4%
ROA
-88.0%
ROIC
261.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $19.3M | 81.7% | $-8.8M | $-10.6M | $— | — |
| Q4 null | $17.6M | 81.2% | $-10.4M | $-11.6M | $— | — |
| FY null | $71.6M | 82.1% | $-41.9M | $-48.6M | $— | — |
| Q3 null | $17.1M | 81.3% | $-9.2M | $-13.2M | $— | — |
| Q2 null | $18.4M | 81.2% | $-11.1M | $-9.9M | $— | — |
| Q1 null | $18.5M | 84.7% | $-11.8M | $-13.9M | $— | — |
| Q4 null | $18.4M | 87.6% | $-10.0M | $-11.6M | $— | — |
| FY null | $64.3M | 85.8% | $-56.6M | $-61.8M | $— | — |
| Q3 null | $19.5M | 83.7% | $-13.8M | $-16.2M | $— | — |
| Q2 null | $15.2M | 86.1% | $-15.6M | $-15.4M | $— | — |
| Q1 null | $11.1M | 86.4% | $-17.2M | $-18.7M | $— | — |
| Q4 2023 | $14.2M | 87.3% | $-12.3M | $-7.1M | $-0.28 | — |